Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
South African Press Association - October 28, 2009
Dr Linda-Gail Bekker received the award in London on Tuesday night for her work on the host response to TB, both with and in the absence of HIV co-infection, spokeswoman Lavinia Crawford-Browne said in a statement.
Bekker is deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and CEO of the Desmond Tutu HIV Foundation. Her research looked at how TB epidemiology has changed in the HIV era.
Crawford-Browne said researchers estimate more than one in 10 South Africans over the age of two was living with HIV in 2008. South Africa has seen a six-fold increase in TB rates in the last 20 years.
Bekker said the HIV/TB public health crisis required innovative thought and research to find novel answers and effective strategies to turn these numbers around.
The Royal Society Pfizer Award includes a 60,000 British pounds (about R747,485) award grant which aims to encourage medical research in Africa by supporting young scientists.
The funding provided by this award would help with research being carried out at Nyanga Primary Health Clinic in Cape Town.
Bekker's team intended collecting positive TB cultures obtained from sputum samples in the clinic, to describe the diversity of TB strains among HIV-positive individuals receiving highly active antiretroviral treatment (Haart), HIV-positive individuals not receiving Haart and HIV-negative individuals. It would also explore health care-associated transmission of TB in the clinic and test drug sensitivities of all cultures.
091028
SA091002
Copyright © 2009 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .